Somatostatin receptor type 2 is a protein associated to possible alternatives to current pituitary tumor treatment  and is particularly effective against TSHomas.
Somatostatin receptor type 2 is a protein associated to possible alternatives to current pituitary tumor treatment  and is particularly effective against TSHomas.